Abstract
Purpose
Lipid accumulation product (LAP) demonstrated a strong predictive accuracy for metabolic syndrome (MetS) in previous studies. This study was conducted to determine the predictive performance of LAP compared to obesity indexes. Moreover, the optimal cutoff point of LAP based on the study population waist circumference threshold was estimated in both men and women.
Methods
5797 subjects with an average age of 44.77 ± 16.77 years for men and 43.78 ± 15.43 years for women were included in the present study. The ROC analysis was performed to assess the predictive accuracy of LAP in the diagnosis of MetS. The optimal cutoff point of LAP was determined according to maximal Youden index in both men and women.
Results
The optimal cutoff points determined for LAP were 49.71 (sensitivity = 85.2 %, specificity = 82.3 %) for women and 39.89 (sensitivity = 86 %, specificity = 79.6 %) for men. Based on the assigned cutoff points, the prevalence of high LAP was obtained 44.1 % in men and 45.1 % in women. LAP also showed a significantly higher predictive performance for MetS compared to obesity measures and also TG.
Conclusion
LAP has a strong and reliable diagnostic accuracy for MetS in Iranian population in the north of Iran. LAP showed a better predictability than other obesity indexes assessed in the present study.
Similar content being viewed by others
References
(2006) International Diabetes Federation: the IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/metabolic-syndrome
Gallagher EJ, LeRoith D, Karnieli E (2011) The metabolic syndrome—from insulin resistance to obesity and diabetes. Med Clin N Am 95(5):855–873
Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S (2013) Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J Am Coll Cardiol 62(8):697–703. doi:10.1016/j.jacc.2013.05.064
Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 287:356–359
Bozorgmanesh M, Hadaegh F, Azizi F (2010) Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 16(9):100
Bozorgmanesh M, Hadaegh F, Azizi F (2010) Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 10(9):45
Yun JE, Won S, Sung J, Jee SH (2012) Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease. Circ J 76(10):2443–2448 Epub 2012 Jul 12
Oladejo AO (2011) Overview of the metabolic syndrome; an emerging pandemic of public health significance. Ann Ib Postgrad Med 9(2):78–82
Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA (2004) Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109(4):551–556
Kahn HS (2005) The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 8(5):26
Xia C, Li R, Zhang S, Gong L, Ren W, Wang Z, Li Q (2012) Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr 66(9):1035–1038
Chiang JK, Koo M (2012) Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovasc Disord 24(12):78
Zamani F, Sohrabi M, Alipour A, Motamed N, Saeedian FS, Pirzad R, Abedi K, Maadi M, Ajdarkosh H, Hemmasi G, Khonsari M (2014) Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: a population based study. Arch Iran Med 17(11):750–754. doi:0141711/AIM.006
Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med 23(5):469–480
Expert Panel on Detection, Evaluation (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19):2486–2497
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645
Taverna MJ, Martínez-Larrad MT, Frechtel GD, Serrano-Ríos M (2011) Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol 164(4):559–567. doi:10.1530/EJE-10-1039
Tellechea ML, Aranguren F, Martínez-Larrad MT, Serrano-Ríos M, Taverna MJ, Frechtel GD (2009) Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires. Diabetes Care 32(7):e85. doi:10.2337/dc08-2284
Wakabayashi I, Daimon T (2014) A strong association between lipid accumulation product and diabetes mellitus in japanese women and men. J Atheroscler Thromb 21(3):282–288
Xiang S, Hua F, Chen L, Tang Y, Jiang X, Liu Z (2013) Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 121(2):115–118. doi:10.1055/s-0032-1333261
Hosseinpanah F, Barzin M, Mirbolouk M, Abtahi H, Cheraghi L, Azizi F (2014) Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran lipid and glucose study. Eur J Prev Cardiol [Epub ahead of print]
Bener A, Yousafzai MT, Darwish S, Al-Hamaq AO, Nasralla EA, Abdul-Ghani M (2013) Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obes 2013:269038. doi:10.1155/2013/269038
Ghazali SM, Sanusi RA (2010) Waist circumference, waist to hip ratio, and body mass index in the diagnosis of metabolic syndrome in Nigerian subjects. Niger J Physiol Sci 25(2):187–195
Wang F, Wu S, Song Y, Tang X, Marshall R, Liang M, Wu Y, Qin X, Chen D, Hu Y (2009) Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese. Nutr Metab Cardiovasc Dis 19(8):542–547
Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM (2009) Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 24(7):1726–1731
Xia C, Li R, Zhang S, Gong L, Ren W, Wang Z, Li Q (2012) Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr 66(9):1035–1038
Wehr E, Gruber HJ, Giuliani A, Möller R, Pieber TR, Obermayer-Pietsch B (2011) The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab 96(6):E986–E990. doi:10.1210/jc.2011-0031
Hosseinpanah F, Barzin M, Erfani H, Serahati S, Ramezani Tehrani F, Azizi F (2014) Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol (Oxf) 81(1):52–57
Acknowledgments
This study was supported by Iran University of Medical Sciences (IUMS). We would like to thank the cooperation of Amol Hefadah Shahrivar Hospital’s staff, health care centers.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest.
Ethical approval
The ethical approval for this study has been approved by the Board of Ethics of the GILDRC affiliated to Iran University of medical sciences.
Informed consent
Each individual patient was asked to fill out the consent form.
Rights and permissions
About this article
Cite this article
Motamed, N., Razmjou, S., Hemmasi, G. et al. Lipid accumulation product and metabolic syndrome: a population-based study in northern Iran, Amol. J Endocrinol Invest 39, 375–382 (2016). https://doi.org/10.1007/s40618-015-0369-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0369-5